Flowvium
Back to Explorer

Stryker Corporation

SYKleader

Stryker is a leading medical technology company known for orthopedic implants, surgical equipment, and the Mako robotic surgery platform. It consistently ranks among the fastest-growing large-cap MedTech companies.

Share:
⇄ Compare

Products & Revenue

Product Revenue Share

Revenue Breakdown ($20.5B)

Static data (loading live financials…)

MedSurg & Neurotechnology (48%)
Orthopedics & Spine (32%)
Other (20%)

Segment Breakdown & Key Customers

Product Details

MedSurg & Neurotechnology48%

Surgical equipment, endoscopy, neurovascular, and patient handling systems

Orthopedics & Spine32%

Joint replacement implants, trauma fixation, and spinal devices

Mako Robotic Surgery20%

Robotic-arm assisted surgical platform for joint replacements

Supply Chain Relationships

Competitors

Johnson & Johnson

Orthopedic implants, surgical instruments

Impact: Primary MedTech competitor

Intuitive Surgical

Robotic surgical platforms

Impact: Robotic surgery competitor

Medtronic

Spinal implants, neurotechnology

Impact: Key competitor in neuro/spine

Macro & Market Context

헬스케어Sector News

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Upcoming Catalysts

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Latest News

Loading news...

AI Analysis

Click "Get AI Analysis" for an AI-powered supply chain analysis of Stryker Corporation.

Company Info

Headquarters

Kalamazoo, Michigan, USA

Founded

1941

Employees

52,000+

Sector Overview — 헬스케어

Sector News

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Key Themes

  • •CMS 메디케어 어드밴티지 수가 인하 → 보험사 마진 압박
  • •AI 영상진단·병리학 도입 가속 — Tempus, Veracyte 수혜
  • •GLP-1 보험 적용 확대 논의 → UNH·CVS 비용 증가 리스크

Upcoming Catalysts

  • ◆CMS 메디케어 최종 수가 발표 (2026.Q2)
  • ◆UNH/HUM/CVS Q1 실적 (2026.04)